Skip to main content

Table 4 Univariate logistic regression analysis of the one injection and retreatment subgroups

From: Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab

Factors

One injection subgroup N = 43

Retreatment subgroup N = 82

OR

95% CI

P value

GA (weeks)

30.6 ± 2.3

29.5 ± 2.1

0.829

0.689,0.998

0.048

BW (g)

1457 ± 418

1289 ± 296

0.999

0.998,1.0

0.053

PMA (weeks)

36.6 ± 2.1

36.09 ± 1.78

0.919

0.745,1.134

0.433

Gender (male/female)

20/8

36/15

1.012

0.453,2.259

0.976

Neutrophil count (*109/L)

2.77 ± 1.56

2.56 ± 1.63

0.894

0.712,1.122

0.333

Lymphocyte count (*109/L)

4.59 ± 1.52

4.94 ± 1.53

1.139

0.885,1.466

0.31

NLR, median (QAR)

0.51 (0.36,0.80)

0.480 (0.272, 0.698)

0.536

0.204,1.41

0.206

INV, n (%)

13 (30.2)

30 (36.6)

1.331

0.604,2.936

0.478

Retinal hemorrhage, n (%)

8 (18.6)

35 (42.7)

3.258

1.346,7.886

0.009

NRDS (treated with mechanical ventilation and surfactant) n (%)

5 (11.6)

6 (7.3)

0.77

0.205,2.889

0.698